Edgewise Therapeutics (EWTX) Stock Research

Edgewise Therapeutics

· EWTX

Dashboard

Financials

Ratios

Valuation

Statistics

4.256 B

+3.60%

Over a week ago

Edgewise Therapeutics price target raised by $12 at H.C. Wainwright, here's why

EWTX

Sep 21, 6:15 AM

Edgewise Therapeutics price target raised by $7 at JPMorgan, here's why

EWTX

Aug 20, 7:16 AM

Edgewise Therapeutics price target raised by $4 at Goldman Sachs

EWTX

Aug 11, 6:12 AM

Edgewise Therapeutics reports Q2 EPS (53c), consensus (47c)

EWTX

Aug 6, 8:15 AM

Edgewise Therapeutics price target raised by $10 at Evercore ISI, here's why

EWTX

Jul 20, 8:49 AM

Edgewise Therapeutics expects to initiate Phase 3 trial of EDG-7500 in Q4

EWTX

Jul 13, 8:39 AM

Edgewise Therapeutics completes sale of sevasemten for up to $2.65B

EWTX

Jul 13, 8:38 AM

Edgewise Therapeutics initiated with bullish view at Oppenheimer, here's why

EWTX

Jul 9, 7:07 AM

Edgewise Therapeutics price target raised by $10 at Guggenheim, here's why

EWTX

Jul 6, 8:17 AM

Edgewise Therapeutics price target raised by $11 at RBC Capital, here's why

EWTX

Jun 17, 8:03 AM

Edgewise Therapeutics price target raised by $12 at Goldman Sachs, here's why

EWTX

Jun 17, 6:13 AM

Edgewise Therapeutics price target raised by $2 at Leerink, here's why

EWTX

Jun 16, 1:53 PM

Edgewise Therapeutics falls -9.9%

EWTX

Jun 16, 10:01 AM

Video: SpaceX cements $60B Cursor takeover

Jun 16, 9:03 AM

Edgewise Therapeutics down 25% at $26.55 after EDG-7500 trial update

EWTX

Jun 16, 7:50 AM

Edgewise Therapeutics' EDG-7500 shows improvements in cardiomyopathy

EWTX

Jun 16, 7:06 AM

Edgewise Therapeutics price target raised by $8 at JPMorgan, here's why

EWTX

Jun 5, 7:22 AM

Acting FDA head vows to block political interference, Endpoint News says

+23

Jun 4, 2:11 PM

Edgewise Therapeutics price target raised by $3 at H.C. Wainwright, here's why

EWTX

Jun 2, 9:43 AM

Edgewise Therapeutics price target lowered by $2 at RBC Capital, here's why

EWTX

Jun 2, 8:41 AM

Edgewise Therapeutics price target raised by $14 at Raymond James, here's why

EWTX

Jun 1, 2:19 PM

Edgewise Therapeutics rises 17.5%

EWTX

Jun 1, 10:00 AM

Edgewise Therapeutics deal 'looks really strong,' says Stifel

EWTX

Jun 1, 9:34 AM

Edgewise Therapeutics confirms sale of sevasemten for up to $2.65B

EWTX

Jun 1, 8:38 AM

Servier to acquire Edgewise Therapeutics' muscular dystrophy business for $2.65B

EWTX

Jun 1, 8:32 AM

Charts